Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 88.39%1.06B | -18.05%3.13B | -14.30%1.91B | -10.75%1.25B | -25.76%563.95M | 7.61%3.82B | -4.08%2.23B | 0.47%1.4B | 15.18%759.59M | -14.97%3.55B |
Refunds of taxes and levies | -31.97%9.19M | -23.49%77.94M | -38.10%47.84M | 8.10%35.01M | -37.29%13.51M | -28.28%101.87M | -29.56%77.29M | -34.57%32.39M | 47.78%21.54M | 151.88%142.03M |
Cash received relating to other operating activities | -8.68%45.73M | 25.70%124.82M | -4.07%301.3M | -5.45%174.27M | -17.72%50.08M | 18.09%99.31M | 106.07%314.08M | 150.93%184.31M | 1,596.45%60.87M | -45.95%84.09M |
Cash inflows from operating activities | 78.05%1.12B | -17.11%3.33B | -13.78%2.26B | -9.77%1.46B | -25.47%627.53M | 6.49%4.02B | 1.32%2.62B | 6.61%1.62B | 24.26%842M | -13.93%3.78B |
Goods services cash paid | -19.87%524.53M | -4.65%2.77B | 11.76%2.03B | 26.37%1.37B | 13.69%654.62M | -9.19%2.91B | -21.19%1.81B | -30.32%1.08B | -18.69%575.77M | -25.07%3.2B |
Staff behalf paid | 22.77%156.34M | 0.22%528.98M | 0.04%383.26M | 0.25%259.94M | -1.11%127.34M | -12.38%527.81M | -14.09%383.11M | -11.35%259.29M | -25.66%128.78M | 11.66%602.39M |
All taxes paid | 84.95%29.67M | 3.74%89.93M | -11.30%74.64M | -10.97%54.75M | -54.09%16.04M | -15.23%86.69M | 11.19%84.15M | 63.53%61.5M | 67.20%34.95M | 93.55%102.26M |
Cash paid relating to other operating activities | 9.00%91.61M | 30.85%279.4M | 0.99%266.96M | 3.41%169.97M | 108.40%84.05M | -41.82%213.53M | 7.09%264.35M | 24.46%164.37M | 2,344.55%40.33M | 18.65%367.01M |
Cash outflows from operating activities | -9.06%802.14M | -1.74%3.67B | 8.11%2.75B | 18.19%1.86B | 13.11%882.06M | -12.59%3.73B | -17.09%2.55B | -22.24%1.57B | -13.40%779.83M | -17.41%4.27B |
Net cash flows from operating activities | 223.84%315.2M | -216.91%-335.98M | -727.39%-489.89M | -903.46%-394.6M | -509.37%-254.52M | 158.00%287.38M | 116.24%78.08M | 109.82%49.11M | 127.90%62.17M | 36.89%-495.48M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | ---- | 80.70%45.88M | -58.89%8.1M | -54.24%8.1M | 169.83%8.1M | -67.51%25.39M | -49.42%19.69M | -40.25%17.69M | -61.34%3M | -74.74%78.15M |
Cash received from returns on investments | -89.44%12.93K | 2.07%54.82M | -82.74%6.12M | -97.56%122.42K | -95.86%122.42K | 89.61%53.71M | 63.58%35.48M | -52.32%5.01M | 42.60%2.96M | -76.66%28.32M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -47.37%6.24M | -52.20%5.83M | -40.45%5.83M | -94.38%95.7K | -26.06%11.85M | 72.54%12.2M | 64.76%9.79M | 988.73%1.7M | 57.72%16.03M |
Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | 940.74%123.56M | 21,232.57%123.56M | 21,232.57%123.56M | 119,376.47%55.56M | -52.93%11.87M |
Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.82%23.7K | 2,215.95%70.3M |
Cash inflows from investing activities | -99.84%12.93K | -50.15%106.94M | -89.50%20.05M | -91.00%14.05M | -86.86%8.31M | 4.80%214.51M | 53.76%190.93M | 123.12%156.05M | 425.39%63.24M | -56.38%204.68M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 81.06%87.46M | -26.92%232.9M | -24.43%158.5M | -26.63%101.37M | -41.61%48.3M | -6.10%318.71M | 35.28%209.74M | 63.48%138.15M | 66.52%82.73M | -12.34%339.42M |
Cash paid to acquire investments | -22.01%22.68M | 666.97%41.22M | -68.11%42.8M | -61.73%40.26M | -72.40%29.08M | -97.34%5.37M | -15.76%134.21M | 29.28%105.21M | 6,804.94%105.37M | -15.88%201.65M |
Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --131.8K | ---- |
Cash outflows from investing activities | 42.33%110.14M | -15.42%274.11M | -41.47%201.3M | -41.80%141.63M | -58.89%77.38M | -40.10%324.08M | 9.42%343.95M | 46.70%243.37M | 267.58%188.24M | -15.58%541.07M |
Net cash flows from investing activities | -59.44%-110.13M | -52.57%-167.17M | -18.45%-181.25M | -46.11%-127.58M | 44.74%-69.07M | 67.43%-109.57M | 19.54%-153.02M | 9.00%-87.32M | -219.08%-124.99M | -95.86%-336.39M |
Financing cash flow | ||||||||||
Cash received from capital contributions | 56,273.75%45.1M | -72.00%280K | -84.00%160K | -84.00%160K | -92.00%80K | -40.30%1M | -32.20%1M | -32.20%1M | -32.20%1M | -97.08%1.68M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | 56,273.75%45.1M | -72.00%280K | -84.00%160K | -84.00%160K | -92.00%80K | 48.15%1M | -32.20%1M | -32.20%1M | -32.20%1M | -92.43%675K |
Cash from borrowing | 2.17%1.13B | 11.41%2.94B | 52.01%2.76B | 70.37%2.22B | 33.52%1.11B | 13.55%2.64B | 7.66%1.82B | 14.16%1.3B | 65.19%831.1M | 52.57%2.32B |
Cash received relating to other financing activities | ---- | --126.33M | ---- | ---- | ---- | ---- | 165.47%367.97M | 56.57%240.82M | ---- | --4.64M |
Cash inflows from financing activities | 6.23%1.18B | 16.17%3.07B | 26.35%2.76B | 43.72%2.22B | 33.37%1.11B | 13.29%2.64B | 19.60%2.19B | 19.14%1.55B | 36.48%832.1M | 47.44%2.33B |
Borrowing repayment | -2.58%1.02B | 34.00%2.57B | 49.21%2.49B | 38.52%1.68B | 57.11%1.05B | 15.62%1.92B | 25.48%1.67B | 32.71%1.21B | 65.68%668.76M | 61.61%1.66B |
Dividend interest payment | -22.00%42.56M | 12.44%169.62M | 30.14%157.45M | -14.87%85.96M | -26.31%54.57M | 29.90%150.85M | 31.46%120.99M | 37.57%100.97M | 244.86%74.05M | -31.12%116.13M |
-Including:Cash payments for dividends or profit to minority shareholders | -33.33%19.6M | -38.89%29.4M | -38.89%29.4M | -38.89%29.4M | -38.89%29.4M | 79.79%48.11M | 79.79%48.11M | 79.79%48.11M | --48.11M | 16.05%26.76M |
Cash payments relating to other financing activities | ---- | -82.84%35.19M | -91.38%26.3M | -80.49%26.16M | ---- | 1,052.54%205.05M | 1,810.23%305.05M | 739.82%134.11M | ---- | -87.92%17.79M |
Cash outflows from financing activities | -3.53%1.07B | 22.04%2.77B | 27.66%2.68B | 23.75%1.79B | 48.79%1.11B | 26.83%2.27B | 45.65%2.1B | 44.34%1.45B | 74.73%742.81M | 33.56%1.79B |
Net cash flows from financing activities | 2,408.39%112.66M | -20.37%290.84M | -5.06%83.23M | 331.99%432.49M | -94.97%4.49M | -31.94%365.26M | -77.35%87.67M | -66.16%100.12M | -51.63%89.29M | 125.83%536.71M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -291.24%-3.78M | -4.29%10.31M | -133.55%-4.78M | -64.05%6.09M | 156.39%1.97M | -53.78%10.77M | -48.50%14.24M | 12.16%16.94M | -264.43%-3.5M | 517.83%23.31M |
Net increase in cash and cash equivalents | 199.00%313.96M | -136.47%-201.99M | -2,297.35%-592.69M | -206.02%-83.6M | -1,480.97%-317.13M | 303.73%553.85M | 110.53%26.97M | 127.64%78.85M | 130.51%22.96M | 62.49%-271.85M |
Add:Begin period cash and cash equivalents | -13.97%1.24B | 62.11%1.45B | 62.11%1.45B | 62.11%1.45B | 62.11%1.45B | -23.36%891.72M | -23.36%891.72M | -23.36%891.72M | -23.36%891.72M | -38.38%1.16B |
End period cash equivalent | 38.03%1.56B | -13.97%1.24B | -7.16%852.88M | 40.33%1.36B | 23.37%1.13B | 62.11%1.45B | 1.25%918.69M | 10.51%970.57M | -15.95%914.68M | -23.36%891.72M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion |
Auditor | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.